HUTCHMED (China) Limited (AIM:HCM)
256.00
+15.00 (6.22%)
Feb 21, 2025, 4:35 PM GMT+1
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
245.34K GBP
Profits / Employee
-16.86K GBP
Market Cap
2.19B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
Genus | 3,500 |
Oxford Nanopore Technologies | 1,238 |
HUTCHMED (China) News
- 3 days ago - HUTCHMED to Announce 2024 Final Results - GlobeNewsWire
- 23 days ago - Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade) - Seeking Alpha
- 5 weeks ago - HUTCHMED (China) Ltd (HCM) Shares Gap Down to $13.87 on Jan 15 - GuruFocus
- 5 weeks ago - Hutchmed (HCM) Shares Drop Over 5.7% Amid Delayed Approvals - GuruFocus
- 5 weeks ago - HUTCHMED (China) Ltd (HCM) Gains Full Approval for ORPATHYS® in China - GuruFocus
- 5 weeks ago - HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC - GlobeNewsWire
- 7 weeks ago - Chinese regulators accept NDA for Orpathys/Tagrisso combo - Seeking Alpha
- 7 weeks ago - Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million - Benzinga